oa Erratum

This is with reference to the article entitled, “Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind, Placebo-Controlled Study”, by Kate X. Zhong, Pierre N. Tariot, Jacobo Mintzer, Margaret C. Minkwitz and Nancy A. Devine, published in Current Alzheimer Research, February 2007, Vol. 4, No. 1, pp. 81-93. The authors unintentionally omitted to include the “Disclosure Information” in the article: DISCLOSURE INFORMATION Pierre N Tariot has received consulting fees and research support from Abbott Laboratories, Bristol-Myers Squibb, Janssen Pharmaceuticals and Eli Lilly & Company. He has also received consulting fees, research support and educational fees from AstraZeneca and Pfizer Inc and research support from the NIA, NIMH, Alzheimer's Association, Arizona Department of Health Services and the Institute for Mental Health Research. Jacobo E Mintzer is a paid consultant and speaker for Abbott Laboratories Inc., AstraZeneca Pharmaceuticals Co., Ltd, Bristol-Myers Squibb, Johnson & Johnson and Pfizer Inc.